|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes |
IUPAC Name ![]() |
| 5-[(3,5-dibutyl-1,2,4-triazol-1-yl)methyl]-2-[2-(2H-tetrazol-5-yl)phenyl]pyridine |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7415 | forasartan |
Synonyms ![]() |
| SC-52458 |
Database Links ![]() |
|
| CAS Registry No. | 145216-43-9 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL315021 |
| DrugBank Ligand | DB01342 |
| PubChem CID | 132706 |
| Search Google for chemical match using the InChIKey | YONOBYIBNBCDSJ-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | YONOBYIBNBCDSJ |
| Search PubMed clinical trials | forasartan |
| Search PubMed titles | forasartan |
| Search PubMed titles/abstracts | forasartan |
| Wikipedia | Forasartan |
| Comments |
| Forasartan is a nonpeptide, competitive and reversible angiotensin II receptor antagonist, selective for the AT1 receptor. Forasartan is not a popular drug of choice for hypertension as it is less effective than losartan, due to its relatively short duration of action. |